| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +1.4M | 89.7% | $10.97 | +$15.4M |
| Sells | 4 | -160K | 10.3% | $18.54 | -$2.97M |
| Net | -1 | +1.24M | 79.5% | +$12.4M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | 10%+ Owner | $346M | +$15M | +4.54% | Feb 18, 2025 |
| Juan C. Jaen | President | $29.1M | -$2.01M | -6.47% | Oct 28, 2025 |
| Terry J. Rosen | Chief Executive Officer, Director | $26M | +$201K | +0.78% | Feb 27, 2025 |
| Yasunori Kaneko | Director | $7.73M | +$201K | +2.67% | Jun 10, 2025 |
| Jennifer Jarrett | Chief Operating Officer | $3.22M | -$750K | -18.9% | Oct 6, 2025 |
| Carolyn Tang | General Counsel | $2.06M | Jan 23, 2025 | ||
| Robert Goeltz II | Chief Financial Officer | $1.84M | -$154K | -7.71% | Oct 28, 2025 |
| Dimitry SA Nuyten | Chief Medical Officer | $1.41M | Dec 15, 2024 | ||
| Kathryn E. Falberg | Director | $1.39M | Jun 10, 2025 | ||
| Richard Markus | Chief Medical Officer | $1.13M | Feb 10, 2025 | ||
| David L. Lacey | Director | $576K | Jun 10, 2025 | ||
| Antoni Ribas | Director | $424K | Jun 10, 2025 | ||
| William Grossman | Chief Medical Officer | $414K | Jun 16, 2021 | ||
| Alexander Azoy | Chief Accounting Officer | $356K | -$58.6K | -14.2% | Sep 29, 2025 |
| Andrew J. Perlman | Director | $346K | Jun 10, 2025 | ||
| Patrick Machado | Director | $313K | Jun 10, 2025 | ||
| Nicole Lambert | Director | $303K | Jun 10, 2025 | ||
| Dietmar Berger | Director | $0 | Feb 6, 2025 | ||
| Johanna Mercier | Director | $0 | Jan 29, 2024 | ||
| Linda Slanec Higgins | Director | Aug 10, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|